Contact DMCA Privacy

Robuta

https://www.ncbi.nlm.nih.gov/Structure/pdb/1R1W
1R1W: CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET
HEPATOCYTE GROWTH FACTOR RECEPTOR
crystal structuretyrosine kinasedomain
https://pubmed.ncbi.nlm.nih.gov/38564707/
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung...
Activating point mutations in the MET tyrosine kinase domain (TKD) are oncogenic in a subset of papillary renal cell carcinomas. Here, using comprehensive...
point mutationsmet kinaseactivatingdomainrepresent
https://pubmed.ncbi.nlm.nih.gov/39960754/
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep...
Mutations in the kinase and juxtamembrane domains of the MET Receptor Tyrosine Kinase are responsible for oncogenesis in various cancers and can drive...
mappingkinasedomainresistancemechanisms
https://pubmed.ncbi.nlm.nih.gov/29045907/
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer...
Inhibitors of the receptor tyrosine kinase c-MET are currently used in the clinic to target oncogenic signaling in tumor cells. We found that concomitant c-MET...
receptor tyrosine kinasereactiveneutrophilresponsesdependent
https://www.rcsb.org/structure/3QTI
RCSB PDB - 3QTI: c-Met Kinase in Complex with NVP-BVU972
c-Met Kinase in Complex with NVP-BVU972
rcsb pdbmet kinasecomplexnvp
https://www.ncbi.nlm.nih.gov/Structure/pdb/3A4P
3A4P: human c-MET kinase domain complexed with 6-benzyloxyquinoline inhibitor
Hepatocyte growth factor receptor(2E)-3-{6-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]quinolin-3-yl}-N-methylprop-2-enamideCHLORIDE IONISOPROPYL ALCOHOL
human cmet kinasedomain